Home › Myasthenia Gravis › NCT07761026
AXIS MG Patient Registry
AXIS Autoimmune Neurology Registry
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Physician-confirmed diagnosis of myasthenia gravis (MG) * Willing and legally able to provide consent * Lives in the United States Exclusion Criteria: * Unwilling or unable to provide consent or comprehend and complete questionnaires * Cognitively impaired adults/unable to comprehend or understand the consent or overall study information
About the study
The goal of the AXIS Autoimmune Neurology Registry is to learn about the experiences of adults living with autoimmune neurological disorders, starting with myasthenia gravis (MG), over time.
The main questions the registry aims to answer are:
* How do symptoms, daily functioning, and quality of life change over time? * What treatments do participants use, and how are these treatments related to their symptoms and health? * What challenges do participants experience with treatment, including side effects, treatment burden, missed doses, and access to care?
Participants will:
* Join the registry and complete an enrollment survey (online or through a mobile app) * Complete a brief online survey about their MG approximately once a month * Provide information that can help confirm their MG diagnosis * Optionally, share their medical records with the research team
This is an observational study. The registry will not assign treatments or ask participants to change their medical care. Information collected through the registry may help researchers better understand MG and improve future research and care.
Sponsor: Autoimmune Neurology Alliance · Participants: 1,000 · Started: Mar 19, 2026
Contact the study team
- AXIS Patient Registry Team · Phone: 765-632-2517
Official record on ClinicalTrials.gov — NCT07761026
Locations in the U.S.
| Massachusetts | Alira Health - Virtual/Remote Site - Can Be Completed 100% Online - All US Residents Accepted, Framingham |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.